Adaptive Biotechnologies Corp vs Atmos Energy Corporation — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Atmos Energy Corporation trades at $168.76 (market cap $28.59B). The key difference: Atmos Energy Corporation is far larger — about 7.1× Adaptive Biotechnologies Corp's market cap, and Atmos Energy Corporation pays a 2.36% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | ATO | |
|---|---|---|
Market Cap | $4.04B | $28.59B |
Sector | Health | Utilities |
52-Week High | $25.45 | $192.25 |
52-Week Low | $12.30 | $162.44 |
Enterprise Value | $4.10B | $38.40B |
Dividend Yield | — | 2.36% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →